PhaseBio Pharmaceuticals Company Information
PhaseBio Pharmaceuticals, Inc.'s employee growth, exchange listings and data sources
- Name: PhaseBio Pharmaceuticals, Inc.
- Ticker: PHAS
- Exchange: NasdaqGM
- Founded: 2002
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Implied Market Cap: US$9.398m
- Shares outstanding: 49.86m
- Website: https://phasebio.com
Number of Employees
- PhaseBio Pharmaceuticals, Inc.
- 1 Great Valley Parkway
- Suite 30
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PHAS||NasdaqGM (Nasdaq Global Market)||Yes||Common Stock||US||USD||Oct 2018|
|2K4||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Oct 2018|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/10/04 00:00|
|End of Day Share Price||2022/10/04 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.